Medication exposure in pregnancy risk evaluation program: the prevalence of asthma medication use during pregnancy.
Medication exposure in pregnancy risk evaluation program: the prevalence of asthma medication use during pregnancy.
复制标题
DOI:
10.1007/s10995-012-1173-x
复制
发表时间:
2013-11
影响因子:
2.3
通讯作者:
Davis R
中科院分区:
文献类型:
--
作者:
Hansen C;Joski P;Freiman H;Andrade S;Toh S;Dublin S;Cheetham C;Cooper W;Pawloski P;Li DK;Beaton S;Kaplan S;Scott P;Hammad T;Davis R
Asthma is one of the most common chronic diseases in women of reproductive age, occurring in up to 8% of pregnancies. Assess the prevalence of asthma medication use during pregnancy in a large diverse cohort. We identified women aged 15 to 45 years who delivered a live born infant between 2001 and 2007 across 11 U.S. health plans within the Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP). Using health plans’ administrative and claims data, and birth certificate data, we identified deliveries for which women filled asthma medications from 90 days before pregnancy through delivery. Prevalence (%) was calculated for asthma diagnosis and medication dispensing. There were 586,276 infants from 575,632 eligible deliveries in the MEPREP cohort. Asthma prevalence among mothers was 6.7%, increasing from 5.5% in 2001 to 7.8% in 2007. A total of 9.7% (n=55,914) of women were dispensed asthma medications during pregnancy. The overall prevalence of maintenance-only medication, rescue-only medication, and combined maintenance and rescue medication was 0.6%, 6.7%, and 2.4% respectively. The prevalence of maintenance-only use doubled during the study period from 0.4% to 0.8%, while rescue-only use decreased from 7.4% to 5.8%. In this large population-based pregnancy cohort, the prevalence of asthma diagnoses increased over time. The dispensing of maintenance-only medication increased over time, while rescue-only medication dispensing decreased over time.
登录
查看更多内容
影响因子:
9.8
作者:
Mitchell AA;Gilboa SM;Werler MM;Kelley KE;Louik C;Hernández-Díaz S;National Birth Defects Prevention Study
通讯作者:
National Birth Defects Prevention Study
影响因子:
7.2
作者:
Berg, Cynthia J.;MacKay, Andrea R.;Callaghan, William M.
通讯作者:
Callaghan, William M.
影响因子:
3.3
作者:
Namazy, JA;Schatz, M
通讯作者:
Schatz, M
影响因子:
2.6
作者:
Raebel, MA;Ellis, JL;Andrade, SE
通讯作者:
Andrade, SE
影响因子:
14.2
作者:
Enriquez, Rachel;Griffin, Marie R.;Hartert, Tina V.
通讯作者:
Hartert, Tina V.